{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:00:06Z","timestamp":1792641606635,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.nucmedbio.2012.09.008","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T03:01:42Z","timestamp":1351825302000},"page":"109-116","source":"Crossref","is-referenced-by-count":27,"title":["Enhanced radiosyntheses of [11C]raclopride and [11C]DASB using ethanolic loop chemistry"],"prefix":"10.1016","volume":"40","author":[{"given":"Xia","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Schnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Fawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.H.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0005","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jlcr.1937","article-title":"Highlighting the versatility of the Tracerlab synthesis modules. Part 2: fully automated production of [11C]-labeled radiopharmaceuticals using a Tracerlab FXC-Pro","volume":"54","author":"Shao","year":"2011","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0010","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1016\/j.apradiso.2008.12.013","article-title":"A simple modification of GE Tracerlab FX C Pro for preparation of [11C] carfentanil and [11C]raclopride","volume":"67","author":"Shao","year":"2009","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0969-8051(00)00132-3","article-title":"Radiotracer synthesis from [11C]-iodomethane: a remarkably simple captive solvent method","volume":"27","author":"Wilson","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/jlcr.1618","article-title":"Utility of commercial radiosynthetic modules in captive solvent [11C]-methylation reactions","volume":"52","author":"Wilson","year":"2009","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0969-8043(00)00368-7","article-title":"A simple loop method for the automated preparation of [11C]raclopride from [11C]methyl triflate","volume":"55","author":"Iwata","year":"2001","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0969-8051(03)00049-0","article-title":"11C-labeled stilbene derivatives as A\u03b2-aggregate-specific PET imaging agents for Alzheimer's disease","volume":"30","author":"Ono","year":"2003","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0035","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/jlcr.722","article-title":"Efficient in-loop synthesis of high specific radioactivity [11C]carfentanil","volume":"46","author":"Studenov","year":"2003","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0040","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jlcr.854","article-title":"A rapid one-step radiosynthesis of the b-amyloid imaging radiotracer N-methyl-[11C]2- (40-methylaminophenyl)-6-hydroxybenzothiazole ([11C]-6-OH-BTA-1)","volume":"47","author":"Wilson","year":"2004","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0045","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/jlcr.1009","article-title":"Alternative methods for labeling the 5-HT1A receptor agonist, 1\u2013[2\u2013(4-fluorobenzoylamino)ethyl]-4-(7-methoxynaphthyl)piperazine (S14506), with carbon-11 or fluorine-18","volume":"48","author":"Lu","year":"2005","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jlcr.1024","article-title":"Simple synthesis of [1-11C]acetate","volume":"49","author":"Le Bars","year":"2006","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0055","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/j.bmcl.2006.03.066","article-title":"Development of new brain imaging agents based upon nocaine-modafinil hybrid monoamine transporter inhibitors","volume":"16","author":"Musachio","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0060","first-page":"1249","article-title":"Imaging prostate cancer with 11C-choline PET\/CT","volume":"47","author":"Reske","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jlcr.1152","article-title":"Rapid preparation of [11C]Flumazenil: captive solvent synthesis combined with purification by analytical sized columns","volume":"50","author":"Cleij","year":"2007","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.nucmedbio.2007.02.009","article-title":"Strategy for improved [11C]DAA1106 radiosynthesis and in vivo peripheral benzodiazepine receptor imaging using microPET, evaluation of [11C]DAA1106","volume":"34","author":"Probst","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1021\/jm0707370","article-title":"Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo","volume":"51","author":"Briard","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1021\/jm0707929","article-title":"Synthesis and in vivo evaluation of halogenated N, N-dimethyl-2-(2\u2032-amino-4\u2032-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands","volume":"51","author":"Jarkas","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0085","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1021\/jm800416m","article-title":"Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging","volume":"51","author":"Donohue","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jlcr.1483","article-title":"New method for routine production of L-[methyl-11C]methionine: in loop synthesis","volume":"51","author":"G\u00f3mez","year":"2008","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0095","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.apradiso.2004.05.051","article-title":"Studies of the mechanism of the in-loop synthesis of radiopharmaceuticals","volume":"61","author":"Studenov","year":"2004","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0100","unstructured":"ICH Harmonised Tripartite Guideline. Impurities: Guideline for Residual Solvents Q3C(R5). 2011:1\u201329."},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0105","unstructured":"Chapter <823> Positron Emission Tomography Drugs for Compounding, Investigational, and Research Uses. USP 35 - NF 50 2012:398\u2013406."},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/anie.198001513","article-title":"Electrophilic reagents \u2013 recent developments and their preparative application","volume":"19","author":"Effenberger","year":"1980","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/ol702627m","article-title":"Efficiency of bulky protic solvent for SN2 reaction","volume":"10","author":"Lee","year":"2008","journal-title":"Org Lett"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0120","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.5012\/bkcs.2009.30.7.1535","article-title":"SN2\/E2 branching in protic solvents: a mechanistic study","volume":"30","author":"Oh","year":"2009","journal-title":"Bull Korean Chem Soc"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jlcr.1586","article-title":"HPLC methods for the purification of [11C]-labelled radiopharmaceuticals: reversal of the retention order of products and precursors","volume":"52","author":"Lehel","year":"2009","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2012.09.008_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.apradiso.2008.08.015","article-title":"Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography","volume":"67","author":"Scott","year":"2009","journal-title":"Appl Radiat Isot"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805112002533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805112002533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T20:51:38Z","timestamp":1540155098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805112002533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0969805112002533"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2012.09.008","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}